Evaluation of targeted therapies in advanced breast cancer: the need for large-scale molecular screening and transformative clinical trial designs
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of targeted therapies in advanced breast cancer: the need for large-scale molecular screening and transformative clinical trial designs
Authors
Keywords
-
Journal
ONCOGENE
Volume 35, Issue 14, Pages 1743-1749
Publisher
Springer Nature
Online
2015-06-29
DOI
10.1038/onc.2015.249
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
- (2014) L. De Mattos-Arruda et al. ANNALS OF ONCOLOGY
- Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
- (2014) F. Rothé et al. ANNALS OF ONCOLOGY
- Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study
- (2014) Eduardo Martínez de Dueñas et al. BREAST CANCER RESEARCH AND TREATMENT
- The AURORA initiative for metastatic breast cancer
- (2014) D Zardavas et al. BRITISH JOURNAL OF CANCER
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- HER2 aberrations in cancer: Implications for therapy
- (2014) Min Yan et al. CANCER TREATMENT REVIEWS
- Anticancer drug development
- (2014) Felipe Ades et al. CURRENT OPINION IN ONCOLOGY
- Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives
- (2014) Felipe Ades et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
- (2014) Fabrice André et al. LANCET ONCOLOGY
- Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
- (2014) Peter Eirew et al. NATURE
- Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial
- (2013) Olöf Bjarnadottir et al. BREAST CANCER RESEARCH AND TREATMENT
- I-SPY 2 may change how clinical trials are conducted
- (2013) Carrie Printz CANCER
- Personalized therapy for breast cancer: a dream or a reality?
- (2013) Dimitrios Zardavas et al. Future Oncology
- Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research
- (2013) Naihua Duan et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Designing Transformative Clinical Trials in the Cancer Genome Era
- (2013) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Emerging targeted agents in metastatic breast cancer
- (2013) Dimitrios Zardavas et al. Nature Reviews Clinical Oncology
- Circulating tumour cells and cell-free DNA as tools for managing breast cancer
- (2013) Leticia De Mattos-Arruda et al. Nature Reviews Clinical Oncology
- Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis
- (2013) E. Curtit et al. ONCOLOGIST
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
- (2012) Linda Sofie Lindström et al. JOURNAL OF CLINICAL ONCOLOGY
- Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657
- (2012) Laura J. Esserman et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequence analysis of mutations and translocations across breast cancer subtypes
- (2012) Shantanu Banerji et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Molecular prescreening to select patient population in early clinical trials
- (2012) Jordi Rodón et al. Nature Reviews Clinical Oncology
- Molecular Alterations Between the Primary Breast Cancer and the Subsequent Locoregional/Metastatic Tumor
- (2012) R. Macfarlane et al. ONCOLOGIST
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
- (2012) Ryan B. Corcoran et al. Cancer Discovery
- Should liver metastases of breast cancer be biopsied to improve treatment choice?
- (2011) G. Curigliano et al. ANNALS OF ONCOLOGY
- Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
- (2011) Sirwan Hadad et al. BREAST CANCER RESEARCH AND TREATMENT
- PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer
- (2011) A. M. Gonzalez-Angulo et al. MOLECULAR CANCER THERAPEUTICS
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- The BATTLE Trial: Personalizing Therapy for Lung Cancer
- (2011) Edward S. Kim et al. Cancer Discovery
- HER2 status in a population-derived breast cancer cohort: discordances during tumor progression
- (2010) Ulla Wilking et al. BREAST CANCER RESEARCH AND TREATMENT
- PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer
- (2010) J. Dupont Jensen et al. CLINICAL CANCER RESEARCH
- Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers
- (2010) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
- (2010) Sunil Badve et al. MODERN PATHOLOGY
- Genome remodelling in a basal-like breast cancer metastasis and xenograft
- (2010) Li Ding et al. NATURE
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
- (2009) C. Simmons et al. ANNALS OF ONCOLOGY
- A Comparison of Phase II Study Strategies
- (2009) S. Hunsberger et al. CLINICAL CANCER RESEARCH
- N-of-1 double-blind, randomized controlled trial of tramadol to treat chronic cough
- (2009) Priscila Gebrim Louly et al. CLINICAL THERAPEUTICS
- Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
- (2009) Sohrab P. Shah et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started